SMART-101 is under clinical development by Smart Immune and currently in Phase II for Refractory Acute Myeloid Leukemia.

SMART-101 is under clinical development by Smart Immune and currently in Phase II for Relapsed Acute Myeloid Leukemia.

You may unsubscribe at any time. By signing up, you agree to our terms of use and privacy policy. This site is protected by ...

Firefighters were on the scene at the Costco in Everett on Saturday, but there were no flames to put out. They were there ...

Players, coaches, and families gathered in North Charleston Saturday for a benefit game in honor of Oceanside basketball ...

The Arizona Cancer Foundation for Children helps support families with sick kids feel normal and find support. Here's how the ...

New research uncovers a terrifying link between pesticides and cancer, showing how farming chemicals may pose a greater risk ...

Early in 2024, we reported on the FDA's call for new boxed warnings on the labeling of all approved chimeric antigen receptor (CAR) T-cell therapies for the potential risk for secondary T-cell ...

Charlotte Cave, a 3-year old girl is battling B-Cell Acute Lymphoblastic Leukemia, along with medical trauma and anxiety.

Emilio Nares would have turned 30 years old Monday. For his parents, Diane and Richard, his birthdays are sacred. They don’t ...

The winning numbers in Sunday evening’s drawing of the "New York Win 4 Evening" game were: ...

Gaza’s health ministry said that 88 people had been killed over the past day. Israeli and Hamas officials have been holding indirect cease-fire talks via mediators in Qatar. By Hiba Yazbek and ...